Embryonic Zebrafish Model - A Well-Established Method for Rapidly Assessing the Toxicity of Homeopathic Drugs - Toxicity Evaluation of Homeopathic Drugs Using Zebrafish Embryo Model -

Abstract

Objectives:Advancements in nanotechnology have led to nanoparticle (NP) use in various fields of medicine. Although the potential of NPs is promising, the lack of documented evidence on the toxicological effects of NPs is concerning. A few studies have documented that homeopathy uses NPs. Unfortunately, very few sound scientific studies have explored the toxic effects of homeopathic drugs. Citing this lack of high-quality scientific evidence, regulatory agencies have been reluctant to endorse homeopathic treatment as an alternative or adjunct treatment. This study aimed to enhance our insight into the impact of commercially-available homeopathic drugs, to study the presence of NPs in those drugs and any deleterious effects they might have, and to determine the distribution pattern of NPs in zebrafish embryos (Danio rerio).Methods:Homeopathic dilutions were studied using high-resolution transmission electron microscopy with selected area electron diffraction (SAED). For the toxicity assessment on Zebrafish, embryos were exposed to a test solution from 4 - 6 hours post-fertilization, and embryos/larvae were assessed up to 5 days post-fertilization (dpf) for viability and morphology. Toxicity was recorded in terms of mortality, hatching delay, phenotypic defects and metal accumulation. Around 5 dpf was found to be the optimum developmental stage for evaluation.Results:The present study aimed to conclusively prove the presence of NPs in all high dilutions of homeopathic drugs. Embryonic zebrafish were exposed to three homeopathic drugs with two potencies (30CH, 200CH) during early embryogenesis. The resulting morphological and cellular responses were observed. Exposure to these potencies produced no visibly significant malformations, pericardial edema, and mortality and no necrotic and apoptotic cellular death.Conclusion:Our findings clearly demonstrate that no toxic effects were observed for these three homeopathic drugs at the potencies and exposure times used in this study. The embryonic zebrafish model is recommended as a well-established method for rapidly assessing the toxicity of homeopathic drugs.

Consumption of Policosanol (Raydel®) Improves Hepatic, Renal, and Reproductive Functions in Zebrafish: In Vivo Comparison Study among Cuban, Chinese, and American Policosanol

“…Among the different in vivo models, zebrafish catches huge attention for preclinical [ 27 ] and toxicological studies [ 28 ] due to its higher homology with the human genome [ 29 ]. Numerous reports suggest that assessing the preclinical efficacy of small molecules in zebrafish has facilitated their transition into clinical trials [ 27 ], highlighting the suitability of zebrafish as an exceptional model for preclinical investigations.…”

Untitled

“…Regarding the safety of high diluted products, Gupta et al (2016) observed the presence of nanoparticles in highly diluted solutions related to patterns of tissue health in zebrafish embryos (Danio rerio) using electron microscopy technique. No toxicity was identified for the embryos (studied by the incidence of malformation, edema, necrotic or apoptotic cell processes, and death), even at different times of exposure.…”

Effect of Acute Exposure of Belladonna Mother Tincture on Zebrafish Embryonic Development

“…The zebrafish model is a vertebrate model that is gaining attention for preclinical drug toxicity and drug screening applications. In zebrafish embryos, cardiovascular, nervous and digestive systems develop in less than 1 w. Therefore their early life stages are most prone to the adverse effects of any external substances [30,31] .…”